Investigation of the utility of apps as adherence-promoting measures
Conditions
Interventions
Group 1: Population 1: Patients who fill a prescription for an antibiotic with multiple daily doses are invited to evaluate an adherence app over a maximum period of 15 days and then complete an onlin
Sponsors
Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Arm 1 includes patients capable of giving informed consent who fill a prescription for an antibiotic to be taken several times a day, such as amoxicillin or amoxicillin/clavulanic acid, and have an interest in monitoring the application over the maximum period of 15 days using an app and are cognitively capable of doing so. Arm 2 includes patients capable of giving consent who take at least five prescribable drugs as long-term medication, including a drug with at least two dosing times, such as metformin, and who are familiar with the use of a mobile phone and at least one app (e.g. alarm clock, email, WhatsApp, etc.), do not currently use apps with a reminder function and are cognitively able to do so.
Exclusion criteria
Exclusion criteria: Participants under the age of 18 who do not independently administer their drug therapy, do not speak German or are cognitively incapable of participating in the study are excluded. In addition, in group 2, a missing or withdrawn consent is an exclusion criterion for participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of various apps using the uMARS-G (German user version of the Mobile Application Rating Scale) in the dimensions of engagement, functionality, aesthetics, information and subjective quality after completion of antibiotic therapy or once in an interview Survey of usability through application observation Identification of possible application problems and barriers in connection with the installation and use of selected apps from the patient's perspective Comparison and contrasting of the uMARS-G quality assessments of the apps by the patients with the assessments by the patients of both arms and with the independent assessments by the research staff | — |
Secondary
| Measure | Time frame |
|---|---|
| Possible suggestions for improving such apps Formulation of further alternative measures to improve adherence from the patient's perspective Derive a possible correlation between the response options and the socio-demographic data | — |
Countries
Germany
Contacts
Public ContactHanna Seidling
Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik
Outcome results
None listed